These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35172694)

  • 1. Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers.
    Bayhan GI; Guner R
    Hum Vaccin Immunother; 2022 Dec; 18(1):2020017. PubMed ID: 35172694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data.
    Copur B; Surme S; Sayili U; Tuncer G; Pehlivanoglu F; Sengoz G
    Future Microbiol; 2022 Nov; 17():1381-1391. PubMed ID: 36169346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers.
    Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Shibata ARO; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):75-81. PubMed ID: 35351217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
    Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
    Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Vaccine Breakthrough Incidence among Health Care Workers Vaccinated with Inactivated SARS-CoV2 Vaccine (CoronaVac).
    Anshory M; Wahono CS; Pratama MZ; Rahman PA; Nugraha AS; Sekarani A
    J Res Health Sci; 2022 Jun; 22(2):e00551. PubMed ID: 36511263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of catching COVID-19 according to vaccination status of healthcare workers during the SARS-CoV-2 Delta variant dominant period and their clinical characteristics.
    Özüdoğru O; Acer Ö; Genç Bahçe Y
    J Med Virol; 2022 Aug; 94(8):3706-3713. PubMed ID: 35419851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
    Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
    Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers.
    Can G; Acar HC; Aydin SN; Balkan II; Karaali R; Budak B; Saltoglu N
    Vaccine; 2022 Apr; 40(18):2574-2579. PubMed ID: 35317942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of primary series CoronaVac vaccine in preventing COVID-19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May-November 2021.
    Katz MA; Rojas Castro MY; Seyidov N; Herdman MT; Mehdiyev S; McKnight CJ; Guseinova A; Cojocaru R; Doran J; Mühlemann B; Drosten C; Suleymanova J; Pebody R; Kissling E; Hagverdiyev G
    Influenza Other Respir Viruses; 2023 Oct; 17(10):e13147. PubMed ID: 37799775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 specific antibody responses in healthcare workers after a third booster dose of CoronaVac or BNT162b2 vaccine.
    Yavuz E; Günal Ö; Başbulut E; Şen A
    J Med Virol; 2022 Aug; 94(8):3768-3775. PubMed ID: 35434796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers].
    Çiçek K; Özkaya Y; Eser E; Buran ZC; Öztürk Arıkan ZÖ; Akçalı S; Erbay Dündar P; Cengiz Özyurt B; Şenol Akar Ş; Özer D; Karadağ Yalçın F
    Mikrobiyol Bul; 2023 Apr; 57(2):238-251. PubMed ID: 37067208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous and Heterologous Covid-19 Booster Vaccinations Against SARS-CoV-2 Infection in the Elderly.
    Acer Ö; Genç Bahçe Y; Özüdoğru O
    Curr Microbiol; 2024 May; 81(7):171. PubMed ID: 38739274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study.
    Huang C; Wei Y; Yan VKC; Ye X; Kang W; Yiu HHE; Shami JJP; Cowling BJ; Tse ML; Castle DJ; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Hayes JF; Chang WC; Chung AKK; Lau CS; Wong ICK; Chan EW
    Lancet Psychiatry; 2023 Jun; 10(6):403-413. PubMed ID: 37141907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells.
    Bilgin H; Marku M; Yilmaz SS; Karahasan Yagci A; Sili U; Can B; Can Sarinoglu R; Mulazimoglu Durmusoglu L; Haklar G; Sirikci O; Eksioglu Demiralp E
    Vaccine; 2022 Apr; 40(18):2619-2625. PubMed ID: 35339303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival.
    Sevinc SA; Metin S; Basi NB; Ling J; Cinar AS; Oba S
    Epidemiol Infect; 2022 Feb; 150():e35. PubMed ID: 35135644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity.
    Kara Z; Akçin R; Demir AN; Dinç HÖ; Taşkın HE; Kocazeybek B; Yumuk VD
    Obes Surg; 2022 Sep; 32(9):2987-2993. PubMed ID: 35802279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CoronaVac and BBIBP-CorV vaccines against SARS-CoV-2 during predominant circulation of Omicron BA.5.2 and BF.7 in China, a retrospective cohort study.
    Hu Z; Jin Z; Zhou M; Zhang C; Bao Y; Gao X; Wang G
    J Med Virol; 2023 Oct; 95(10):e29143. PubMed ID: 37814963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.